Skip to Content

State Street International Stock Sel K SSIQX

Medalist Rating as of | See State Street Investment Hub
  • NAV / 1-Day Return 10.71  /  −0.56 %
  • Total Assets 129.1 Mil
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Average
  • Share Class Type Retirement, Large
  • Category Foreign Large Value
  • Investment Style Large Value
  • Min. Initial Investment
  • Status Open
  • TTM Yield 5.55%
  • Turnover 106%

USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0

Morningstar’s Analysis SSIQX

Will SSIQX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

State Street International Stock Sel K's Average Process Pillar and People Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SSIQX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 14.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novartis AG Registered Shares

2.12 2.8 Mil
Healthcare

Sanofi SA

1.52 2.0 Mil
Healthcare

GSK PLC

1.45 1.9 Mil
Healthcare

Mitsubishi Corp

1.38 1.8 Mil
Industrials

Msci Eafe Mar24 Ifus 20240315

1.38 1.8 Mil

CRH PLC

1.37 1.8 Mil
Basic Materials

Munchener Ruckversicherungs-Gesellschaft AG

1.36 1.8 Mil
Financial Services

Deutsche Telekom AG

1.36 1.8 Mil
Communication Services

Mitsui & Co Ltd

1.34 1.8 Mil
Industrials

Novo Nordisk A/S Class B

1.33 1.8 Mil
Healthcare